Stuart B. Levy, M.D. - Publications

Affiliations: 
Molecular Biology and Microbiology Tufts University, Boston 
Area:
Antimicrobial resistance
Website:
http://www.tuftsmedicalcenter.org/apps/TuftsFindAPhysician/PhysicianDetail.aspx?OID=1921

80 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Molina-Quiroz RC, Silva-Valenzuela C, Brewster J, Castro-Nallar E, Levy SB, Camilli A. Cyclic AMP Regulates Bacterial Persistence through Repression of the Oxidative Stress Response and SOS-Dependent DNA Repair in Uropathogenic Escherichia coli. Mbio. 9. PMID 29317513 DOI: 10.1128/Mbio.02144-17  0.313
2016 McNamara PJ, Levy SB. Triclosan: An Instructive Tale. Antimicrobial Agents and Chemotherapy. PMID 27736758 DOI: 10.1128/Aac.02105-16  0.34
2015 Honeyman L, Ismail M, Nelson ML, Bhatia B, Bowser TE, Chen J, Mechiche R, Ohemeng K, Verma AK, Cannon EP, Macone A, Tanaka SK, Levy S. Structure-Activity Relationship of the Aminomethylcyclines and the Discovery of Omadacycline. Antimicrobial Agents and Chemotherapy. 59: 7044-53. PMID 26349824 DOI: 10.1128/Aac.01536-15  0.368
2015 Dalhoff AA, Levy SB. Does use of the polyene natamycin as a food preservative jeopardise the clinical efficacy of amphotericin B? A word of concern. International Journal of Antimicrobial Agents. 45: 564-7. PMID 25862309 DOI: 10.1016/J.Ijantimicag.2015.02.011  0.321
2013 Warner DM, Duval V, Levy SB. The contribution of PmrAB to the virulence of a clinical isolate of Escherichia coli. Virulence. 4: 634-7. PMID 23921442 DOI: 10.4161/Viru.25931  0.314
2013 Levy SB, Marshall BM. Honeybees and tetracycline resistance. Mbio. 4: e00045-13. PMID 23404397 DOI: 10.1128/Mbio.00045-13  0.368
2013 Warner DM, Yang Q, Duval V, Chen M, Xu Y, Levy SB. Involvement of MarR and YedS in carbapenem resistance in a clinical isolate of Escherichia coli from China. Antimicrobial Agents and Chemotherapy. 57: 1935-7. PMID 23318808 DOI: 10.1128/Aac.02445-12  0.363
2012 Marshall BM, Robleto E, Dumont T, Levy SB. The frequency of antibiotic-resistant bacteria in homes differing in their use of surface antibacterial agents. Current Microbiology. 65: 407-15. PMID 22752336 DOI: 10.1007/S00284-012-0172-X  0.324
2012 Lister IM, Raftery C, Mecsas J, Levy SB. Yersinia pestis AcrAB-TolC in antibiotic resistance and virulence. Antimicrobial Agents and Chemotherapy. 56: 1120-3. PMID 22083483 DOI: 10.1128/Aac.05338-11  0.358
2012 Lichtenstein SJ, De Leon L, Heller W, Marshall B, Cupp G, Foster K, McLean C, Levy S, Stroman DW. Topical ophthalmic moxifloxacin elicits minimal or no selection of fluoroquinolone resistance among bacteria isolated from the skin, nose, and throat. Journal of Pediatric Ophthalmology and Strabismus. 49: 88-97. PMID 22074357 DOI: 10.3928/01913913-20111101-02  0.309
2011 Nelson ML, Levy SB. The history of the tetracyclines. Annals of the New York Academy of Sciences. 1241: 17-32. PMID 22191524 DOI: 10.1111/J.1749-6632.2011.06354.X  0.31
2011 Bush K, Courvalin P, Dantas G, Davies J, Eisenstein B, Huovinen P, Jacoby GA, Kishony R, Kreiswirth BN, Kutter E, Lerner SA, Levy S, Lewis K, Lomovskaya O, Miller JH, et al. Tackling antibiotic resistance. Nature Reviews. Microbiology. 9: 894-6. PMID 22048738 DOI: 10.1038/Nrmicro2693  0.359
2011 Marshall BM, Levy SB. Food animals and antimicrobials: impacts on human health. Clinical Microbiology Reviews. 24: 718-33. PMID 21976606 DOI: 10.1128/Cmr.00002-11  0.342
2011 Livermore DM, Blaser M, Carrs O, Cassell G, Fishman N, Guidos R, Levy S, Powers J, Norrby R, Tillotson G, Davies R, Projan S, Dawson M, Monnet D, Keogh-Brown M, et al. Discovery research: the scientific challenge of finding new antibiotics Journal of Antimicrobial Chemotherapy. 66: 1941-1944. PMID 21700626 DOI: 10.1093/Jac/Dkr262  0.318
2011 Garbeva P, Silby MW, Raaijmakers JM, Levy SB, Boer Wd. Transcriptional and antagonistic responses of Pseudomonas fluorescens Pf0-1 to phylogenetically different bacterial competitors. The Isme Journal. 5: 973-85. PMID 21228890 DOI: 10.1038/Ismej.2010.196  0.305
2011 Ruiz C, Levy SB. Use of functional interactions with MarA to discover chromosomal genes affecting antibiotic susceptibility in Escherichia coli. International Journal of Antimicrobial Agents. 37: 177-8. PMID 21185159 DOI: 10.1016/J.Ijantimicag.2010.10.007  0.379
2010 Warner DM, Levy SB. Different effects of transcriptional regulators MarA, SoxS and Rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon. Microbiology (Reading, England). 156: 570-8. PMID 19926649 DOI: 10.1099/Mic.0.033415-0  0.335
2010 Lister IM, Mecsas J, Levy SB. Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis. Infection and Immunity. 78: 364-71. PMID 19841071 DOI: 10.1128/Iai.00904-09  0.35
2009 Roberts RR, Hota B, Ahmad I, Scott RD, Foster SD, Abbasi F, Schabowski S, Kampe LM, Ciavarella GG, Supino M, Naples J, Cordell R, Levy SB, Weinstein RA. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1175-84. PMID 19739972 DOI: 10.1086/605630  0.331
2009 Marshall BM, Ochieng DJ, Levy SB. Commensals: Underappreciated reservoir of antibiotic resistance Microbe. 4: 231-238. DOI: 10.1128/Microbe.4.231.1  0.369
2008 Carson RT, Larson E, Levy SB, Marshall BM, Aiello AE. Use of antibacterial consumer products containing quaternary ammonium compounds and drug resistance in the community. The Journal of Antimicrobial Chemotherapy. 62: 1160-2. PMID 18694904 DOI: 10.1093/Jac/Dkn332  0.363
2008 Levy SB. Genome size and antibiotic resistance. Antimicrobial Agents and Chemotherapy. 52: 2696. PMID 18577753 DOI: 10.1128/Aac.01024-07  0.372
2008 McDermott PF, McMurry LM, Podglajen I, Dzink-Fox JL, Schneiders T, Draper MP, Levy SB. The marC gene of Escherichia coli is not involved in multiple antibiotic resistance. Antimicrobial Agents and Chemotherapy. 52: 382-3. PMID 17954692 DOI: 10.1128/Aac.00930-07  0.352
2007 Aiello AE, Larson EL, Levy SB. Consumer antibacterial soaps: effective or just risky? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: S137-47. PMID 17683018 DOI: 10.1086/519255  0.331
2006 Udani RA, Levy SB. MarA-like regulator of multidrug resistance in Yersinia pestis. Antimicrobial Agents and Chemotherapy. 50: 2971-5. PMID 16940090 DOI: 10.1128/Aac.00015-06  0.374
2006 Nicoloff H, Perreten V, McMurry LM, Levy SB. Role for tandem duplication and lon protease in AcrAB-TolC- dependent multiple antibiotic resistance (Mar) in an Escherichia coli mutant without mutations in marRAB or acrRAB. Journal of Bacteriology. 188: 4413-23. PMID 16740948 DOI: 10.1128/Jb.01502-05  0.368
2006 Ades S, Maxfield LF, Gould CJ, Jones GK, Levy SB. Selection of non-P-glycoprotein mediated high-level etoposide resistant cell lines by adriamycin with P-gp inhibitors. International Journal of Oncology. 28: 747-53. PMID 16465381 DOI: 10.3892/Ijo.28.3.747  0.326
2005 Aiello AE, Marshall B, Levy SB, Della-Latta P, Lin SX, Larson E. Antibacterial cleaning products and drug resistance. Emerging Infectious Diseases. 11: 1565-70. PMID 16318697 DOI: 10.3201/Eid1110.041276  0.335
2005 Stelling JM, Travers K, Jones RN, Turner PJ, O'Brien TF, Levy SB. Integrating Escherichia coli antimicrobial susceptibility data from multiple surveillance programs. Emerging Infectious Diseases. 11: 873-82. PMID 15963282 DOI: 10.3201/Eid1106.041160  0.311
2004 Aiello AE, Marshall B, Levy SB, Della-Latta P, Larson E. Relationship between triclosan and susceptibilities of bacteria isolated from hands in the community. Antimicrobial Agents and Chemotherapy. 48: 2973-9. PMID 15273108 DOI: 10.1128/Aac.48.8.2973-2979.2004  0.304
2003 Robleto EA, López-Hernández I, Silby MW, Levy SB. Genetic analysis of the AdnA regulon in Pseudomonas fluorescens: nonessential role of flagella in adhesion to sand and biofilm formation. Journal of Bacteriology. 185: 453-60. PMID 12511490 DOI: 10.1128/Jb.185.2.453-460.2003  0.305
2002 Levy SB. Active efflux, a common mechanism for biocide and antibiotic resistance. Symposium Series (Society For Applied Microbiology). 65S-71S. PMID 12481830 DOI: 10.1046/J.1365-2672.92.5S1.4.X  0.361
2001 Walson JL, Marshall B, Pokhrel BM, Kafle KK, Levy SB. Carriage of antibiotic-resistant fecal bacteria in Nepal reflects proximity to Kathmandu. The Journal of Infectious Diseases. 184: 1163-9. PMID 11598839 DOI: 10.1086/323647  0.342
2001 Alekshun MN, Levy SB, Mealy TR, Seaton BA, Head JF. The crystal structure of MarR, a regulator of multiple antibiotic resistance, at 2.3 A resolution. Nature Structural Biology. 8: 710-4. PMID 11473263 DOI: 10.1038/90429  0.328
2001 Wang H, Dzink-Fox JL, Chen M, Levy SB. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrobial Agents and Chemotherapy. 45: 1515-21. PMID 11302820 DOI: 10.1128/Aac.45.5.1515-1521.2001  0.366
2001 Koutsolioutsou A, Martins EA, White DG, Levy SB, Demple B. A soxRS-constitutive mutation contributing to antibiotic resistance in a clinical isolate of Salmonella enterica (Serovar typhimurium). Antimicrobial Agents and Chemotherapy. 45: 38-43. PMID 11120941 DOI: 10.1128/Aac.45.1.38-43.2001  0.369
1999 Levy SB, McMurry LM, Barbosa TM, Burdett V, Courvalin P, Hillen W, Roberts MC, Rood JI, Taylor DE. Nomenclature for new tetracycline resistance determinants. Antimicrobial Agents and Chemotherapy. 43: 1523-4. PMID 10348788 DOI: 10.1128/Aac.43.6.1523  0.347
1998 Levy SB. Antimicrobial resistance: bacteria on the defence. Resistance stems from misguided efforts to try to sterilise our environment. Bmj (Clinical Research Ed.). 317: 612-3. PMID 9727983 DOI: 10.1136/Bmj.317.7159.612  0.372
1998 Oethinger M, Podglajen I, Kern WV, Levy SB. Overexpression of the marA or soxS regulatory gene in clinical topoisomerase mutants of Escherichia coli. Antimicrobial Agents and Chemotherapy. 42: 2089-94. PMID 9687412 DOI: 10.1128/Aac.42.8.2089  0.351
1998 McDermott PF, White DG, Podglajen I, Alekshun MN, Levy SB. Multidrug resistance following expression of the Escherichia coli marA gene in Mycobacterium smegmatis. Journal of Bacteriology. 180: 2995-8. PMID 9603894 DOI: 10.1128/Jb.180.11.2995-2998.1998  0.38
1997 Moken MC, McMurry LM, Levy SB. Selection of multiple-antibiotic-resistant (mar) mutants of Escherichia coli by using the disinfectant pine oil: roles of the mar and acrAB loci. Antimicrobial Agents and Chemotherapy. 41: 2770-2. PMID 9420057 DOI: 10.1128/Aac.41.12.2770  0.336
1997 Alekshun MN, Levy SB. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrobial Agents and Chemotherapy. 41: 2067-75. PMID 9333027 DOI: 10.1128/Aac.41.10.2067  0.385
1997 White DG, Goldman JD, Demple B, Levy SB. Role of the acrAB locus in organic solvent tolerance mediated by expression of marA, soxS, or robA in Escherichia coli. Journal of Bacteriology. 179: 6122-6. PMID 9324261 DOI: 10.1128/Jb.179.19.6122-6126.1997  0.317
1997 Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 25: 584-99. PMID 9314444 DOI: 10.1086/513766  0.356
1997 Draper MP, Martell RL, Levy SB. Indomethacin-mediated reversal of multidrug resistance and drug efflux in human and murine cell lines overexpressing MRP, but not P-glycoprotein. British Journal of Cancer. 75: 810-5. PMID 9062400 DOI: 10.1038/Bjc.1997.145  0.322
1997 Draper MP, Martell RL, Levy SB. Active efflux of the free acid form of the fluorescent dye 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein in multidrug-resistance-protein-overexpressing murine and human leukemia cells. European Journal of Biochemistry / Febs. 243: 219-24. PMID 9030742 DOI: 10.1111/J.1432-1033.1997.0219A.X  0.326
1997 Martell RL, Slapak CA, Levy SB. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3. British Journal of Cancer. 75: 161-8. PMID 9010020 DOI: 10.1038/Bjc.1997.27  0.303
1997 Shlaes DM, Gerding DN, John JF, Craig WA, Bornstein DL, Duncan RA, Eckman MR, Farrer WE, Greene WH, Lorian V, Levy S, McGowan JE, Paul SM, Ruskin J, Tenover FC, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Infection Control and Hospital Epidemiology. 18: 275-291. DOI: 10.2307/30141215  0.356
1996 Bhushan A, Slapak CA, Levy SB, Tritton TR. Expression of c-fos precedes MDR3 in vincristine and adriamycin selected multidrug resistant murine erythroleukemia cells. Biochemical and Biophysical Research Communications. 226: 819-21. PMID 8831695 DOI: 10.1006/Bbrc.1996.1434  0.335
1996 Maneewannakul K, Levy SB. Identification for mar mutants among quinolone-resistant clinical isolates of Escherichia coli. Antimicrobial Agents and Chemotherapy. 40: 1695-8. PMID 8807064 DOI: 10.1128/Aac.40.7.1695  0.369
1996 Goldman JD, White DG, Levy SB. Multiple antibiotic resistance (mar) locus protects Escherichia coli from rapid cell killing by fluoroquinolones. Antimicrobial Agents and Chemotherapy. 40: 1266-9. PMID 8723480 DOI: 10.1128/Aac.40.5.1266  0.377
1994 Ariza RR, Cohen SP, Bachhawat N, Levy SB, Demple B. Repressor mutations in the marRAB operon that activate oxidative stress genes and multiple antibiotic resistance in Escherichia coli. Journal of Bacteriology. 176: 143-8. PMID 8282690 DOI: 10.1128/Jb.176.1.143-148.1994  0.341
1994 McMurry LM, George AM, Levy SB. Active efflux of chloramphenicol in susceptible Escherichia coli strains and in multiple-antibiotic-resistant (Mar) mutants. Antimicrobial Agents and Chemotherapy. 38: 542-6. PMID 8203852 DOI: 10.1128/Aac.38.3.542  0.375
1994 Nelson ML, Park BH, Levy SB. Molecular requirements for the inhibition of the tetracycline antiport protein and the effect of potent inhibitors on the growth of tetracycline-resistant bacteria. Journal of Medicinal Chemistry. 37: 1355-61. PMID 8176712 DOI: 10.1021/Jm00035A016  0.331
1993 Nelson ML, Park BH, Andrews JS, Georgian VA, Thomas RC, Levy SB. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines. Journal of Medicinal Chemistry. 36: 370-7. PMID 8426364 DOI: 10.1021/Jm00055A008  0.32
1993 Cohen SP, Hächler H, Levy SB. Genetic and functional analysis of the multiple antibiotic resistance (mar) locus in Escherichia coli. Journal of Bacteriology. 175: 1484-92. PMID 8383113 DOI: 10.1128/Jb.175.5.1484-1492.1993  0.335
1993 Cohen SP, Yan W, Levy SB. A multidrug resistance regulatory chromosomal locus is widespread among enteric bacteria. The Journal of Infectious Diseases. 168: 484-8. PMID 8335992 DOI: 10.1093/Infdis/168.2.484  0.368
1993 Summers AO, Wireman J, Vimy MJ, Lorscheider FL, Marshall B, Levy SB, Bennett S, Billard L. Mercury released from dental "silver" fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrobial Agents and Chemotherapy. 37: 825-34. PMID 8280208 DOI: 10.1128/Aac.37.4.825  0.368
1993 Cohen SP, Levy SB, Foulds J, Rosner JL. Salicylate induction of antibiotic resistance in Escherichia coli: activation of the mar operon and a mar-independent pathway. Journal of Bacteriology. 175: 7856-62. PMID 7504664 DOI: 10.1128/Jb.175.24.7856-7862.1993  0.359
1992 McMurry LM, Stephan M, Levy SB. Decreased function of the class B tetracycline efflux protein Tet with mutations at aspartate 15, a putative intramembrane residue. Journal of Bacteriology. 174: 6294-7. PMID 1328154 DOI: 10.1128/Jb.174.19.6294-6297.1992  0.337
1991 Hächler H, Cohen SP, Levy SB. marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli. Journal of Bacteriology. 173: 5532-8. PMID 1715857 DOI: 10.1128/Jb.173.17.5532-5538.1991  0.351
1990 Rubin RA, Levy SB, Heinrikson RL, Kézdy FJ. Gene duplication in the evolution of the two complementing domains of gram-negative bacterial tetracycline efflux proteins. Gene. 87: 7-13. PMID 2332166 DOI: 10.1016/0378-1119(90)90489-E  0.306
1990 Levy SB. Starting life resistance-free. The New England Journal of Medicine. 323: 335-7. PMID 2195348 DOI: 10.1056/Nejm199008023230509  0.362
1989 Levy SB, McMurry LM, Burdett V, Courvalin P, Hillen W, Roberts MC, Taylor DE. Nomenclature for tetracycline resistance determinants. Antimicrobial Agents and Chemotherapy. 33: 1373-4. PMID 2802561 DOI: 10.1128/Aac.33.8.1373  0.33
1989 Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB. Cross-resistance to fluoroquinolones in multiple-antibiotic-resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrobial Agents and Chemotherapy. 33: 1318-25. PMID 2679373 DOI: 10.1128/Aac.33.8.1318  0.363
1988 Hickman RK, Levy SB. Evidence that TET protein functions as a multimer in the inner membrane of Escherichia coli. Journal of Bacteriology. 170: 1715-20. PMID 3280550 DOI: 10.1128/Jb.170.4.1715-1720.1988  0.321
1988 Park BH, Levy SB. The cryptic tetracycline resistance determinant on Tn4400 mediates tetracycline degradation as well as tetracycline efflux. Antimicrobial Agents and Chemotherapy. 32: 1797-800. PMID 3072922 DOI: 10.1128/Aac.32.12.1797  0.369
1988 Cohen SP, McMurry LM, Levy SB. marA locus causes decreased expression of OmpF porin in multiple-antibiotic-resistant (Mar) mutants of Escherichia coli. Journal of Bacteriology. 170: 5416-22. PMID 2848006 DOI: 10.1128/Jb.170.12.5416-5422.1988  0.33
1987 Park BH, Hendricks M, Malamy MH, Tally FP, Levy SB. Cryptic tetracycline resistance determinant (class F) from Bacteroides fragilis mediates resistance in Escherichia coli by actively reducing tetracycline accumulation. Antimicrobial Agents and Chemotherapy. 31: 1739-43. PMID 3324960 DOI: 10.1128/Aac.31.11.1739  0.367
1987 McMurry LM, Park BH, Burdett V, Levy SB. Energy-dependent efflux mediated by class L (tetL) tetracycline resistance determinant from streptococci. Antimicrobial Agents and Chemotherapy. 31: 1648-50. PMID 3324958 DOI: 10.1128/Aac.31.10.1648  0.352
1986 Marshall B, Morrissey S, Flynn P, Levy SB. A new tetracycline-resistance determinant, class E, isolated from Enterobacteriaceae. Gene. 50: 111-7. PMID 3034728 DOI: 10.1016/0378-1119(86)90315-X  0.361
1986 McMurry LM, Hendricks M, Levy SB. Effects of toluene permeabilization and cell deenergization on tetracycline resistance in Escherichia coli. Antimicrobial Agents and Chemotherapy. 29: 681-6. PMID 3010853 DOI: 10.1128/Aac.29.4.681  0.368
1984 Marshall B, Roberts M, Smith A, Levy SB. Homogeneity of transferable tetracycline-resistance determinants in Haemophilus species. The Journal of Infectious Diseases. 149: 1028-9. PMID 6330236 DOI: 10.1093/Infdis/149.6.1028  0.322
1983 George AM, Levy SB. Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. Journal of Bacteriology. 155: 531-40. PMID 6348022 DOI: 10.1128/Jb.155.2.531-540.1983  0.377
1983 George AM, Levy SB. Gene in the major cotransduction gap of the Escherichia coli K-12 linkage map required for the expression of chromosomal resistance to tetracycline and other antibiotics. Journal of Bacteriology. 155: 541-8. PMID 6307967 DOI: 10.1128/Jb.155.2.541-548.1983  0.367
1982 McMurry LM, Cullinane JC, Levy SB. Transport of the lipophilic analog minocycline differs from that of tetracycline in susceptible and resistant Escherichia coli strains. Antimicrobial Agents and Chemotherapy. 22: 791-9. PMID 6758689 DOI: 10.1128/Aac.22.5.791  0.368
1982 Levy SB. Microbial resistance to antibiotics. An evolving and persistent problem. Lancet. 2: 83-8. PMID 6123819 DOI: 10.1016/S0140-6736(82)91701-9  0.347
1980 Mendez B, Tachibana C, Levy SB. Heterogeneity of tetracycline resistance determinants. Plasmid. 3: 99-108. PMID 6927764 DOI: 10.1016/0147-619X(80)90101-8  0.335
1978 Levy SB, McMurry L. Plasmid-determined tetracycline resistance involves new transport systems for tetracycline. Nature. 276: 90-2. PMID 368642 DOI: 10.1038/276090A0  0.378
1976 Levy SB, Rubenstein CB, Friend C. The spleen in Friend leukemia. I. Prolonged survival of leukemic mice after autoimplantation of spleen tissue. Journal of the National Cancer Institute. 56: 1183-8. PMID 1069138 DOI: 10.1093/Jnci/56.6.1183  0.485
Show low-probability matches.